Parkinson's Awareness Walk (PAW) - Sept. 8^th

Plans are underway at the Presbyterian Homes & Services for the Ted Kroll Memorial 5th Annual Parkinson's Awareness Walk. The goal is to raise funds to build a specialized Parkinson's Residence that offers a homelike atmosphere as well as additional space for research, therapy, and gardens, including an atrium.

It will have advanced technology including telemedicine that will meet the needs of the individuals dealing with Parkinson’s disease. All staff will be trained and educated to familiarize themselves with the unique challenges of those with Parkinson ’s disease. This will include management of medications, therapy, dietary needs with an emphasis on socialization, offering multiple activities and outings.  

This year we have changed the categories for the highest pledge total awarded to first, second and third place. We will begin and end this event at the main entrance of Presbyterian Home. Our event continues to be a mile long party that is wheelchair and walker friendly.

Our Grand Marshall/Honoree this year is Mike Austin, vice president and director of corporate communications of Utica National Insurance in New Hartford, NY. Get your friends, family, co-workers or acquaintances to walk with you, form a team or give support as a sponsor. For more information, call (315) 272-2222.

Walk details are as follows:

* Pre-registration – WED. Sept. 5 11am-2pm P.K. Miller Room, Presbyterian Home

* Saturday Sept. 8 – Registration starts at 8:30 am

* WALK BEGINS at 10:00 am

* Registration is $25 per person

* Every walker must be registered to receive a T-shirt.

SUPPORT PAW!!

Join in the fun!

FDA OKs Drug Patch to Treat Parkinson’s

The treatment options for patients with early Parkinson’s expanded in May 2007 with the approval of a new drug in patch form.

The once-daily Neupro patch contains a drug called rotigotine, which has not been sold before in the United States, the Food and Drug Administration said. The drug patch, made by Schwarz Pharma AG, is the first for the treatment of symptoms of Parkinson’s disease.

Parkinson’s disease results from the loss of dopamine-producing brain cells. Dopamine is crucial for the communication between cells that control muscle movement, which explains the trembling commonly seen in Parkinson’s patients.

Rotigotine works by activating dopamine receptors in the brain, mimicking the neurotransmitter’s effect. The most common side effects for Neupro include skin reactions at the patch site, dizziness, nausea, vomiting, drowsiness and insomnia, the FDA said. Most are typical with this class of drugs.

Other potential safety concerns include sudden onset of sleep while engaged in activities such as driving or operating machinery, hallucinations and decreased blood pressure when standing up, the agency said.

Mailing list

Please notify us if you move or want your name added or removed from our mailing list.

PLEASE CHECK ONE:

q Add to mailing list

q Delete from mailing list

q Change address to:

Name_________________________

Address_______________________

_______________________

Mail to: Central NY Parkinson’s

Support Group, Inc.

705 Ronald St.

Herkimer, NY 13350

5